The activation of CD4 + T cells is accompanied by increased growth, proliferation and specification into functional effector T cell (T eff cell) or regulatory T cell (T reg cell) subsets that promote or suppress immunity and subsequent inflammatory resolution. To support this transition from quiescent naive T cells to T eff cells and T reg cells, activated CD4 + T cells reprogram their cellular metabolism 1 . Resting T cells utilize a catabolic oxidative metabolism of glucose, lipids and amino acids. After being activated via co-stimulation, however, T cells upregulate the expression of glucose and amino acid transporters and increase their metabolic rate. Although both mitochondrial oxidative phosphorylation and glycolytic metabolism increase, glycolytic flux is elevated to a greater degree. In T eff cells, this leads to a predominantly glycolytic phenotype that is reminiscent of the proliferative metabolism of cancer cells, aerobic glycolysis, that is thought to provide biosynthetic intermediates for anabolic cell growth 2 . CD4 + T eff cells are dependent on the glucose transporter Glut1 and aerobic glycolysis for proliferation and inflammatory functions, as inhibition of glycolysis or deletion of Glut1 impairs T eff cell function in vivo 3, 4 . In contrast, induced T reg cells have been shown to utilize mainly a distinct metabolic program based on mitochondrial oxidation of lipid and pyruvate [5] [6] [7] [8] , and T reg cells can act independently of Glut1 in vivo 4 . This oxidative metabolism provides inefficient support for biosynthesis for cell growth. However, T reg cells can be highly proliferative and glycolytic in vivo 9, 10 . Although T reg cell are important in autoimmunity 9 and inflammatory resolution and healing [11] [12] [13] , the mechanisms that regulate T reg cell metabolism and how these metabolic pathways affect T reg cell proliferation and function remain poorly understood.
The activation of CD4 + T cells is accompanied by increased growth, proliferation and specification into functional effector T cell (T eff cell) or regulatory T cell (T reg cell) subsets that promote or suppress immunity and subsequent inflammatory resolution. To support this transition from quiescent naive T cells to T eff cells and T reg cells, activated CD4 + T cells reprogram their cellular metabolism 1 . Resting T cells utilize a catabolic oxidative metabolism of glucose, lipids and amino acids. After being activated via co-stimulation, however, T cells upregulate the expression of glucose and amino acid transporters and increase their metabolic rate. Although both mitochondrial oxidative phosphorylation and glycolytic metabolism increase, glycolytic flux is elevated to a greater degree. In T eff cells, this leads to a predominantly glycolytic phenotype that is reminiscent of the proliferative metabolism of cancer cells, aerobic glycolysis, that is thought to provide biosynthetic intermediates for anabolic cell growth 2 . CD4 + T eff cells are dependent on the glucose transporter Glut1 and aerobic glycolysis for proliferation and inflammatory functions, as inhibition of glycolysis or deletion of Glut1 impairs T eff cell function in vivo 3, 4 . In contrast, induced T reg cells have been shown to utilize mainly a distinct metabolic program based on mitochondrial oxidation of lipid and pyruvate [5] [6] [7] [8] , and T reg cells can act independently of Glut1 in vivo 4 . This oxidative metabolism provides inefficient support for biosynthesis for cell growth. However, T reg cells can be highly proliferative and glycolytic in vivo 9, 10 . Although T reg cell are important in autoimmunity 9 and inflammatory resolution and healing [11] [12] [13] , the mechanisms that regulate T reg cell metabolism and how these metabolic pathways affect T reg cell proliferation and function remain poorly understood.
Signals through the transcription factors Myc and HIF1α, or the PI(3)K-Akt-mTORC1 pathway 1 and transcription factors of the CD4 + T cell subset 14, 15 , facilitate the induction of Glut1 expression and aerobic glycolysis in T eff cells. The PI(3)K-Akt-mTOR pathway has also been suggested to be a regulator of T reg cell metabolism. However, T reg cells do not require mTOR kinase 16 . Furthermore, although PI(3)KAkt-mTOR signaling can be activated in T reg cells 17, 18 , selective loss of mTORC1 (ref. 18) or constitutive activation of mTORC1 as a result of deficiency in the lipid phosphatase PTEN or the tumor suppressor TSC2 leads to increased numbers of T reg cells, but those T reg cells have impaired capacity for immunosuppression [19] [20] [21] . Although mTORC1 regulates protein translation and other aspects of cell physiology beyond anabolic metabolism, T reg cell metabolism might be heterogeneous or oscillatory 17 , and these changes could affect T reg cell function and proliferation.
Another signaling mechanism that modulates T reg cell proliferation and function is signaling through TLRs. T reg cells express several 1 4 6 0 VOLUME 17 NUMBER 12 DECEMBER 2016 nature immunology
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TLRs, including TLR1, TLR2, TLR4, TLR5 and TLR8 (refs. 22-25) . In each case, ligation of the TLR leads to increased T reg cell proliferation but reduced suppressive function [23] [24] [25] [26] . Pattern recognition via TLR signaling appears to be critical for T reg cell homeostasis and function, as microbiota can promote the loss of Foxp3 expression on intestinal T reg cells 27 and T reg cells deficient in the TLR adaptor-transducer MyD88 are reduced in number in the gut, which leads to the onset of inflammatory bowel disease (IBD) 28 . Similarly, microbiota that provide TLR ligands have been shown to be important for driving T reg cell proliferation in the skin 29 . TLR ligation has also been shown to activate PI(3)K-Akt-mTORC1 signaling through modulation of PI(3)Kγ in macrophages 30 and to induce glycolysis in B cells 31 and dendritic cells 32 . However, the role of TLR signals as modulators of T reg cell metabolism and how metabolic pathways balance the anabolic growth and proliferation of T reg cells with suppression remain unknown.
We investigated mechanisms that regulate T reg cell metabolism and how changes in glucose metabolism affect T reg cell proliferation and function. Although most T reg cell used a catabolic metabolism with low Glut1 expression, proliferating T reg cell showed elevated Glut1 levels and mTOR activity. Ligation of TLR1 and TLR2 on activated T reg cells further increased glycolysis and proliferation, but the cells' suppressive capacity was reduced in an mTORC1-dependent manner. Conversely, Foxp3 opposed PI(3)K-Akt-mTOR signaling, reducing glycolytic and anabolic metabolism while increasing the activity of oxidative and catabolic pathways. These metabolic changes directly modified T reg cell function, as transgenic expression of Glut1 in T cells 33 reduced T reg cell suppressive capacity and led to the downregulation of Foxp3. Thus, TLR signals and Foxp3 counter-regulate T reg cell metabolism to balance proliferation and suppressive function.
RESULTS
Proliferative T reg cells activate mTORC1 and glucose uptake To assess the regulation and role of T reg cell metabolism in proliferation and function, we first investigated the metabolic programs of proliferative and non-proliferative T reg cell 34 . Foxp3 + thymusderived T reg cells (tT reg cells) were more proliferative than Foxp3 − CD4 + T cells were under homeostatic conditions, as determined by staining for the proliferation marker Ki67 (Supplementary Fig. 1a) . The tT reg cells with high Ki67 expression (Ki67 hi ), however, were phenotypically distinct from those with low Ki67 expression (Ki67 lo ). Consistent with glycolysis being an anabolic metabolic program that supports proliferation, Ki67 hi tT reg cells had increased Glut1 expression (Fig. 1a) . mTORC1 activity was also elevated in Ki67 hi tT reg cells, as measured by phosphorylated ribosomal protein S6 (Fig. 1b) . Thus, tT reg cells were not metabolically uniform, and those cells that had undergone proliferation showed increased expression of markers of glycolysis.
TLR1, TLR2 promote iT reg glycolysis but impair suppression We next assessed the effect of T reg cell activation on glucose metabolism. Although proliferative tT reg cells had higher surface expression of Glut1 protein than that of non-proliferative tT reg cells, Glut1 expression was even higher in activated induced T reg cells (iT reg cells) (Fig. 2a) . T reg cells express TLR1 and TLR2 at high levels 22 and can respond to TLR ligation with increased proliferation 24 . Treatment of activated iT reg cells with the TLR1 and TLR2 agonist Pam 3 CSK 4 further increased the expression of Glut1 and hexokinase 2 (HK2), an enzyme that phosphorylates intracellular glucose (Fig. 2a,b) . This was accompanied by a sharp increase in T reg cell size (Supplementary Fig. 1b) , glycolytic lactate production ( Fig. 2c and Supplementary Fig. 1c) , activation of the mTORC1 pathway, and proliferation, as determined by Ki67 expression (Fig. 2d) . To determine how TLR1-and TLR2-induced changes in T reg cell signaling and metabolism affect T reg cell function, we treated iT reg cells overnight with vehicle or Pam 3 CSK 4 and then re-purified the cells. TLR-ligand-treated iT reg cells showed decreased capacity to suppress effector CD8 + T cells and instead increased T eff cell proliferation (Fig. 2e) . Activation of mTORC1 signaling by Pam 3 CSK 4 was critical for the subsequent decrease in T reg cell suppressive capacity, as treatment with the mTORC1 inhibitor rapamycin together with ligation of TLR1 and TLR2 before re-purification restored the ability of iT reg cells to suppress the proliferation of T eff cells (Fig. 2e) .
Foxp3 promotes oxidative metabolic gene expression
Genetic deletion of Foxp3 leads to a loss of T reg cell suppressive function and a broad inflammatory autoimmune disorder 35 . Foxp3 expression has also been reported to diminish Glut1 expression and Akt activity 36 . We therefore examined published data sets to determine whether deletion of Foxp3 also altered T cell metabolism and markers of mTORC1 signaling. Following deletion of Foxp3, tT reg cells were reported to induce widespread changes in gene expression that included not only genes encoding immunological products but a large number of genes encoding products that regulate or participate in varied metabolic pathways (Supplementary Fig. 1d) . Alterations in the expression of genes that regulate primary metabolic process included protein products involved in PI(3)K-Akt-mTORC1 signaling as well as glucose metabolism, such as PTEN, phosphofructokinase, enolase 2, transketolase, triosephosphate isomerase and others (Supplementary Table 1 ). Consistent with the inverse relationship of Foxp3 and PI(3)K signaling, it has also been reported that tT reg cell activation in vivo correlates with a diminished Aktrelated gene-expression signature 37 .
To directly test how Foxp3 affects the expression of genes encoding products involved in metabolism, we stimulated CD4 + T cells in vitro under neutral conditions and transduced them to express Foxp3. Pathway analysis revealed that the group of genes with significantly altered expression in Foxp3-expressing cells showed enrichment for those encoding products involved in metabolic pathways (Fig. 3a) .
In particular, genes encoding products involved in lipid and peptide hormone metabolism pathways were upregulated, whereas those encoding products involved in glucose and nucleotide-metabolism pathways were downregulated. A comparison of genes altered by increased Foxp3 and those reported to change following genetic deletion of Foxp3 (ref. 35 ) revealed an overlap of numerous genes encoding products involved in metabolism (Supplementary Table 2 ). Both metabolic and immune regulatory pathways were broadly altered (Supplementary Table 3 ). Although the regulatory mechanisms were unclear, analysis of Foxp3-bound loci by chromatin immunoprecipitation and sequencing showed that Foxp3 associated with genes encoding the pyruvate dehydrogenase kinase PDK3 and the catalytic γ-subunit of PI(3)K (PI(3)Kcγ) ( Supplementary Fig. 1e ), which correlated with decreased expression (Supplementary Figs. 1f and 2a) . Together these data indicated that Foxp3 regulated metabolic gene expression both directly and indirectly through modulation of the PI(3)K-Akt-mTORC1 pathway.
Foxp3 inhibits PI(3)K-Akt-mTORC1 signaling and glycolysis We next assessed the effect of Foxp3 expression on metabolic proteins and pathways. Consistent with reduced PI(3)Kcγ expression and PI(3)K activity, Foxp3 expression led to diminished phosphorylation of Akt, S6 kinase and S6 relative to that of T cells transduced with a control vector (Fig. 3b) . In addition, Foxp3 expression was sufficient to reduce the expression of Glut1 and HK2 and to increase the level of HK1 protein (Fig. 3c) , similar to the expression pattern of T reg cells 6 . Foxp3 expression in T cells led to lower glucose uptake and glycolysis, but the oxygen consumption rate (OCR) and the ratio of oxygen consumption to lactate production (OCR/extracellular media acidification rate (ECAR)) increased ( Fig. 3d-g ). We next transduced the mouse pro-B cell line FL5.12 to express a conditionally active Foxp3; activated Foxp3 led to reduced phosphorylation of S6 kinase, Akt and mTOR, and we observed lower amounts of PI(3)Kcγ and HIF1α protein in this setting (Supplementary Fig. 2a) . Conversely, PTEN protein was modestly increased by activation of Foxp3 (Supplementary Fig. 2a) . Expression of the mitochondrial proteins cytochrome C and CPT1a increased, whereas the expression of Glut1, HK2 and the majority of glycolytic enzymes decreased ( Supplementary Fig. 2b ,c and Supplementary Table 4 ). Activation of Foxp3 in FL5.12 cells was also sufficient to promote an oxidative shift, with reprogramming of the metabolome to increase catabolic metabolites and decrease many anabolic metabolites ( Supplementary  Fig. 2d and Supplementary Table 5 ). Altered metabolites included increased succinyl-carnitine, which is indicative of mitochondrial metabolism, and decreased glucoseamine-6-phosphate, glyceraldehyde-3-phosphate and N-carbamoyl-aspartate, which are indicative of glycosylation, glycolysis and pyrimidine synthesis, respectively ( Supplementary Fig. 2e ). Foxp3 activation led to decreased glucose uptake, glycolysis, lactate production and pentose-phosphate-pathway flux ( Fig. 4a-d) . Conversely, oxygen consumption, the OCR/ ECAR ratio, pyruvate oxidation and palmitate oxidation all increased ( Fig. 4e-h ). Not all pathways were altered, however, as glutamine oxidation remained unchanged (Fig. 4i) . Consistent with diminished A r t i c l e s anabolic metabolism, Foxp3 slowed the rate at which cells accumulated in vitro (Fig. 4j) . Together these data indicated that TLR signals promoted T reg cell proliferation, PI(3)K-Akt-mTORC1 activation and glycolysis, whereas Foxp3 promoted oxidative metabolism and slowed anabolic metabolism and growth.
Akt promotes T reg cell growth but inhibits suppressive capacity To directly test how the metabolic transitions noted above affect T reg cell phenotype and function, we modified the Akt-mTORC1 signaling and metabolism of T reg cells through the use of mice with transgenic T cell-specific expression of constitutively active Akt (Akt-tg mice) or Glut1 (Glut1-tg mice) 7 . tT reg cells isolated from Akt-tg mice had increased glucose uptake and diminished reactive oxygen species (ROS) than that of tT reg cells from wild-type mice ( Supplementary  Fig. 3a ,b), and were more abundant in Akt-tg mice than in wild-type mice ( Supplementary Fig. 3c,d ). Akt-tg T reg cell were also enlarged and had altered cell surface markers that were consistent with activation ( Supplementary Fig. 3e-i ). Similar to TLR1-and TLR2-stimulated T reg cells and consistent with poor suppression by T reg cells deficient in the tumor suppressors PTEN or TSC2 (refs. 19-21) , Akt-tg T reg cells were less able to suppress T eff cell proliferation than were control wild-type T reg cells (Supplementary Fig. 3j ).
Glut1 enhances T reg cell growth, but reduces function
Foxp3 and TLR signals might, in principle, modify T reg cell metabolism and function through control of Glut1 expression and glycolysis.
To directly assess the role of Glut1 in the regulation in T reg cell function, we studied tT reg cells from Glut1-tg mice ex vivo 33 . Glut1-tg CD4 + T cells showed increased Glut1 expression and glucose uptake, whereas ROS were diminished ( Supplementary Fig. 4a-c) , relative to that of wild-type cells. Glut1-tg T reg cells also had higher ECAR and OCR than that of wild-type control T reg cells ( Supplementary  Fig. 4d ). Glut1-tg tT reg cells accumulated in terms of both numbers and frequency (Fig. 5a,b ) and were modestly enlarged (Fig. 5c) . However, Glut1-tg mice develop autoimmunity with age 7 , which suggests that their T reg cell function is impaired. Consistent with altered function, tT reg cells from Glut1-tg mice had a greater proportion of CD25 lo Foxp3 + cells than did those from wild-type mice ( Supplementary  Fig. 4e ). We also observed a modestly increased frequency of Helios − Foxp3 + CD4 + T cells in Glut1-tg mice (Supplementary Fig. 4f ), which might indicate a greater frequency of peripherally induced T reg cells or lower T reg cell suppressive capacity.
To better assess the effect of Glut1 on T reg cells, we activated and induced wild-type control and Glut1-tg T cells to generate Glut1-tg iT reg cells. Similar to tT reg cells, Glut1-tg iT reg cells were generated at an increased frequency, were enlarged and had reduced expression of the cytokine receptor CD25 (IL-2Rα), relative to that of wild-type control iT reg cells (Supplementary Fig. 5a-c) . Unlike tT reg cells, Glut1-tg iT reg cells also showed reduced expression of the co-stimulatory receptor ICOS, relative to that of control iT reg cells (Supplementary Fig. 5d ). In two cohorts of control and Glut1-tg iT reg cells, we found, by RNA sequencing, that Glut1 expression altered the expression of genes encoding products involved in both metabolism and immunological function (Fig. 5d) . These changes included upregulation of Ifng and Tbx21 (which encodes the transcription factor T-bet), and downregulation of Foxp3, Il2ra (CD25), Foxo1 and Bcl6. Gene-ontology analysis of significantly altered genes revealed enrichment for the expression of genes encoding products involved in T cell activation, cytokine signaling and regulation of epigenetic mechanism pathways (Supplementary Table 6 ). Similarly, quantitative-PCR array analysis of wild-type control and Glut1-tg iT reg cells also showed numerous differences in gene expression, including downregulation of Foxp3, Icos, Pdcd1 (PD-1), Gata3 and Tnfrs8 (CD30) ( Supplementary  Fig. 5e and Supplementary Table 6 ). We assessed expression of CD25, Foxp3, the transcription factor ID3 and the histone methyltransferase EZH2 by flow cytometry and found that expression of all of them was reduced in Glut1-tg iT reg cells ( Fig. 5e and Supplementary Fig. 4e) . A portion of Glut1-tg T reg cells also showed altered cytokine expression, with decreased Il-10 ( Supplementary  Fig. 5e ) and an increase in the population of IFN-γ-producing cells and a decrease in the population of IL-2-producing cells ( Fig. 5f and Supplementary Fig. 5f ). Consistent with reduced expression of functional T reg cell markers, induced Glut1-tg T reg cells had reduced in vitro suppressive capacity relative to that of control iT reg cells ( Fig. 5g and Supplementary Fig. 6a ).
Lower stability of Glut1-expressing T reg cells in vivo in IBD The phenotypic changes noted above suggested that increased glucose metabolism altered or reduced the suppressive function or stability of T reg cells in vivo. To test whether the Glut1-tg T reg cell were functionally impaired in vivo, we depleted naive T cell populations of T reg cells and adoptively transferred the resultant cells into lymphopenic mice to induce IBD. After disease onset, we gave some of the host mice injection of CD4 + CD25 + CD45Rb lo tT reg cells sorted from wild-type control or Glut1-tg mice (Supplementary Fig. 6b ). Despite potential alterations from transgenic Glut1 expression, we found no substantial difference between the CD4 + CD25 + CD45Rb lo tT reg cell populations in their frequency of Foxp3-expressing cells ( Supplementary  Fig. 6c ). As expected, control tT reg cells reversed disease progression, and the mice began to gain weight (Fig. 6a) . Glut1-tg tT reg cells, however, slowed disease progression only partially (Fig. 6a) . At the termination of the experiment, we found that Glut1-tg tT reg cells had restrained T eff cell accumulation less effectively than control tT reg cells had (Fig. 6b) . Despite the transfer of similar initial numbers of tT reg cells, CD4 + Foxp3 + T cells from Glut1-tg donors were also significantly less frequent than were control T reg cells (Fig. 6c) . Foxp3 expression was significantly reduced (P = 0.003) in transferred Glut1-tg T reg cells in both mesenteric lymph nodes (Fig. 6d) and spleen ( Supplementary Fig. 6d ). Reduced Foxp3 expression was confirmed by transfer of congenically marked control and Glut1-tg T reg cells; this revealed that increased T reg cell glycolysis in IBD led to T reg cell downregulation of Foxp3 expression ( Fig. 6e and Supplementary  Fig. 6e ). Together these data showed that increased glucose uptake altered T reg cell phenotype and Foxp3 expression in vivo. Foxp3 and TLR signals therefore act to balance T reg cell metabolism and regulate the proliferation, function and potential stability of T reg cells (Supplementary Fig. 6f ).
DISCUSSION T reg cells have been shown to rely mainly on the mitochondrial oxidative metabolic pathways of lipid and pyruvate [5] [6] [7] [8] . However, this mode of metabolism supports anabolic growth pathways only inefficiently, and T reg cell can be highly proliferative in vivo 9 . T reg cell have also been found to be capable of inducing glycolysis 17, 18 , but the mechanisms by which this occurs remain unclear. We found that T reg cell metabolism was dynamically regulated by TLR signals and Foxp3 to balance the anabolic metabolism and proliferation of T reg cells with suppressive capacity. T reg cells responded to activation and TLR ligation by increasing Glut1 expression and glycolysis. Conversely, Foxp3 decreased Glut1 expression and glycolytic and anabolic metabolism to instead favor mitochondrial oxidative pathways. Similar inhibition of glycolysis has also been described for Foxo1 (ref. 38) , which suggests that these two T reg cell transcription factors might induce a barrier to aerobic glycolysis that favors suppression. In contrast, inflammatory signals via TLR1 and TLR2 ligation stimulated glucose uptake and downregulated Foxp3 expression. This model suggests that metabolic changes in acute infection or inflammation provide signals that promote T reg cell glycolysis and proliferation while limiting suppressive A r t i c l e s capacity to allow T eff cells to eliminate the invading pathogen. As inflammatory signals decrease, Foxp3 levels might increase and tilt the metabolic balance away from glycolysis to favor mitochondrial oxidative pathways instead. Although this would decrease proliferation, this shift might increase suppressive capacity and promote wound healing and inflammatory resolution. The metabolic heterogeneity of T reg cell that we observed might reflect the breadth of T reg cell phenotypes observed in vivo. T reg cells derived from the thymus or periphery, resting or activated by antigen or distinct stimuli, or circulating or tissue resident have each been shown to have distinct immunological and gene-expression phenotypes 9, 39 . Increased glucose metabolism resulting from Glut1 expression leads to an accumulation of T reg cells that is reminiscent of effector T reg cells 40 , but with several key differences. In particular, T reg cells with elevated Glut1 downregulated Foxp3 expression and suppressive capacity and seemed to have potentially reduced stability.
Thus, although glucose metabolism contributes to T reg cell phenotypes and heterogeneity, T reg cell function and stability also depend on other factors and stimuli.
The direct regulation of metabolism by the central T reg cell transcription factor Foxp3 ensures that metabolic pathways are matched to functional demands. Similar regulation of T cell metabolism by key subset transcription factors has been described for the transcription factor RORγt in the T H 17 subset of helper T cells 14 and the transcription factor Bcl6 in follicular helper T cells 15 . Foxp3 can suppress T reg cell glycolysis through several mechanisms, including both direct metabolic targets and inhibition of PI(3)K-Akt-mTORC1 signaling. Indeed, Foxp3 has been shown to lead to reduced activation of Akt 36 , and Foxp3 activation leads to a gene-expression signature of diminished Akt function 37 . In addition to potential regulation of the Akt phosphatase PHLPP 36 , Foxp3 might repress this pathway by suppressing PI(3)K signaling and PI(3)Kcγ expression. We also 
Tnip1 Tlr6 found that Foxp3 associated with the locus encoding Pdk3, which led to reduced expression of Pdk3; this suggested that Foxp3 might repress expression of this kinase to allow increased mitochondrial oxidation of pyruvate in direct suppression of glycolysis. Consistent with a potential role for Pdk3 in regulating T reg function, inhibition of Pdk1 has been shown to lead to increased generation and suppressive activity of T reg cells in vivo, which improves protection from asthma and experimental autoimmune encephalomyelitis 6, 41 . T reg cell are stimulated by antigens, cytokines and inflammatory signals. We found that T reg cells increased their PI(3)K-Akt-mTORC1 signaling when proliferating under homeostatic conditions and after activation. Ligation of TLR1 and TLR2 on activated T reg cells led to the greatest upregulation of Glut1 expression and glycolysis. Those findings are consistent with the proposal of a role for PTEN in suppressing PI(3)K-Akt-mTORC1 signaling in T reg cells following stimulation with antigen and cytokines 19, 20 . The mechanism by which ligation of TLR1 and TLR2 led to activation of the PI(3)K-Akt-mTORC1 pathway in T reg cells is not clear but might involve activation through PI(3)Kcγ 30 , which we identified as a potential target of Foxp3 repression. In addition to activating PI(3)K-Akt-mTORC1, TLR signaling also substantially activates the transcription factor NF-κB 42 , which might also modulate metabolism and contribute to the regulation of T reg cell proliferation and function. Consistent with a role for alternative pathways, TLR activation in dendritic cells leads to Akt activation and glycolysis, in part through activation of the kinase TBK1-kinase IKKε pathway in a mechanism independent of PI(3)K 32, 43 .
Increased glucose uptake on T reg cells involved in an IBD response resulted in a sharp reduction in Foxp3 expression. Although these cells did not widely lose Foxp3 expression and convert to T eff cells, as formerly T reg cells, an increased portion of Glut1-tg T reg cells were found to secrete IFN-γ, which suggested that T reg cell stability was decreased. Similarly, Glut1-tg T reg cells had downregulated expression of CD25, which is also a marker of reduced T reg cell stability 19 . Prior to IBD, however, resting Glut1-tg T reg cells showed only modestly lower Foxp3 expression, which indicated that activation and inflammatory signals were needed to more substantially downregulate Foxp3. Our finding that Glut1-tg T reg cells had normal or modestly enhanced mitochondrial function but much greater glycolysis suggested that increased glycolysis itself might promote lower Foxp3 expression. The elevated glycolysis that occurs in PTEN-or TSC1-deficient T reg cells [19] [20] [21] might therefore directly lead to the downregulation of Foxp3 mRNA and protein.
Together our data have described a dynamic regulation of T reg cell metabolism with a glycolytic switch influencing anabolic metabolism for growth and proliferation or oxidative metabolism for maximal suppressive capacity. Metabolic separation of T reg cell proliferation and T reg cell suppression might allow kinetic resolution of T cell function. T reg cells could accumulate in damaged or inflamed tissues without substantially impairing the protective immune response and are involved in inflammatory resolution and healing [11] [12] [13] . Although multiple signals also strongly influence T reg cell proliferation and function, metabolic regulation is a key contributor. The role of TLR signals in increasing T reg cell glycolysis and proliferation while reducing suppression is further demonstrated in the interactions of T reg cells with microbiota [23] [24] [25] [26] [27] [28] 39 . Microbe-derived metabolites can drive T reg cells to maintain homeostasis and tolerance, but physical contact and TLR ligation that indicate invading pathogenic bacteria instead allow proliferation and inflammatory function. Similarly, T reg cells often accumulate in but fail to suppress inflammation in chronic autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis 44, 45 . Conversely, these pathways might promote the suppressive function of T reg cells in tumors, in which glycolysis might be limited by reduced glucose or elevated lactate concentrations. Understanding the metabolic signaling and roles in T reg cells might define new regulatory mechanisms and potential targets to modulate immunity.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. GEO: RNAseq data, GSE84919; ArrayExpress: microarray data, E-MTAB-4561. T reg suppression assay. T reg cells were differentiated as described above and cultured at ratios of 1:1, 1:2 and 1:4 with CellTrace Violet (CTV) labeled CD8 + T cells along with 1 µg/mL of anti-CD3 antibody and irradiated feeder splenocytes (30Gy). T reg suppression of effector T cell proliferation was determined 72 h post stimulation by CTV dilution of target population using flow cytometry.
Foxp3-ER cell lines. FL5.12 cells were infected with control or Foxp3-ER expressing lentivirus and selected with NGFR. The Foxp3-ER-NGFR construct was generously provided by M. Levings (University of British Columbia) and has been described previously 47 . Three clones of each were selected based on equivalent NGFR expression and were Mycoplasma negative. To activate Foxp3-ER, 100 nM 4-hydroxytamoxifen (4-OHT) was added 36 h before experimental procedures.
Retroviral packaging. Retroviral constructs were packaged in Plat-E cells.
Plat-E cells were maintained in DMEM supplemented with 10% FBS, with 1 µg/mL puromycin and 10 µg/mL blasticidin. To produce virus, Plat-E cells at 70% confluency in a six-well dish were transfected with construct plasmid along with Lipofectamine 2000 Transfection Reagent (Life Technologies). Media supernatant was removed 24 h post transfection, and fresh virus was collected at 72 and 96 h post transfection.
Retroviral Foxp3 expression.
Primary CD4 + CD25 -T cells were isolated from mice and stimulated with 3 ng/ml PMA and 1 µM ionomycin overnight. Cells were then treated with MSCV-Foxp3-NGFR or MSCV-NGFR control retroviral supernatant containing 8 µg/ml polybrene and centrifuged for 90 min at 2,500 rpm. Cells were rested for 5 h and then plated with fresh media and 10 U/ml interleukin-2 for 72 h. Foxp3-NGFR or NGFR control cells were positively selected with PE magnetic beads following NGFR-PE labeling (≥90% purity, Miltenyi Biotec).
Microarray gene expression analysis. Total RNA from activated transduced cells was isolated using TRIzol reagent (Invitrogen), and dissolved in RNasefree water. Total RNA treated with RNase-free DNase and cleaned up using Qiagen RNeasy columns. Biotinylated antisense cRNA was prepared by two rounds of amplification using the BioArray RNA Amplification and Labeling system according to the protocol for 10-1,000 ng of input RNA. cDNA libraries were amplified and hybridized to Affymetrix GeneChip Mouse Gene 1.0 ST array at the Nucleic Acid and Protein core facility of the Children's Hospital of Philadelphia Research Institute. Array data were normalized and differential expression was determined using Utils, Stats, Samr, RankProd, topGO and Bioconductor. Significance was assessed using significance analysis of microarrays (SAM). Data are deposited in ArrayExpress (accession E-MTAB-4561). Genes differing in intensity by at least 1.5-fold (up or down) with P < 0.001 were considered Foxp3-regulated. Functional annotation of the top 200 FOXP3-regulated genes was achieved using DAVID software 48 , and network analyses of the same gene sets were generated using Ingenuity software. Williams and Rudensky 35 gene expression array data from wild-type and Foxp3-deficient Treg were analyzed using Geo Data set Browser Data Analysis Tools to select genes with 1.5 fold expression change (P < 0.1) for gene ontology with PANTHER 49 . Genes overlapping between Foxp3 expression or deficient T reg were analyzed for gene ontology and pathway enrichment with DAVID.
ChIP-seq. Foxp3-chromatin complexes were immunoprecipitated from Foxp3-or empty-vector-transduced CD4 + T cells as described previously 50 . Genomic DNA libraries were constructed from these samples using NEBNext Ultra DNA Library Prep kits (NEB) and sequenced using the HiSeq platform (Illumina). Sequence reads were mapped to mm9 using Bowtie, and HOMER software was used to identify read densities (peaks) enriched significantly (>5-fold) in ChIP samples over input controls. The top 30% of peaks were highly enriched for the Foxp3 consensus binding sequence (>85%), and were used as the set of high confidence, genome-wide Foxp3 binding sites.
RNA-seq of iT reg . Glut1-tg (n = 4) and wild-type (control; n = 5) mice were used as naive T cell donors to generate iT reg in two age-matched groups. Group 1 included control 1, 3 and Glut1-tg 2, 3, and 5 and Group 2 included control 2, 4, 5 and Glut1-tg 1. RNA was isolated from Glut1-transgenic and control Treg cells using the RNeasy Plus Mini kit (Qiagen) following the manufacturers' instructions. Libraries were prepared with Illumina TruSeq Stranded mRNA sample kits using indexed adaptors (Illumina). Pooled libraries were subjected to 75-bp paired-end sequencing according to the manufacturer's protocol (Illumina HiSeq3000). Targeted sequencing depth was 30 million paired-end reads per sample. Bcl2fastq2 Conversion Software (Illumina) was used to generate de-multiplexed Fastq files. The RNA reads obtained from sequencing were mapped with the TopHat 2 aligner using the default parameters to the UCSC mm10 mouse reference genome. Reads were examined for quality control and quantified using FeatureCounts. Subsequently, raw counts were normalized taking into account library sizes, filtering out genes with near zero expression, and the variance-stabilizing transformation was applied to the remaining genes (n = 13700) using the DESeq2 software package. Data are deposited in Geo Database (accession GSE84919). Statistical analyses were performed in the R Statistical Computing Environment. Differential gene expression was assessed between Glut1-tg and wild-type iT reg samples, while at the same time adjusting for animal age groups. Benjamini-Hochberg false discovery rate (FDR) correction was subsequently used to account for multiple testing, and genes were considered to be differentially expressed (DE) if the corrected P < 0.05. To visualize gene expression differences between experimental groups, a heatmap was generated using the top 1000 most variably expressed genes. The mean expression values Glut1-tg and wildtype iT reg blocked by age groups were used as heatmap input. Functional analysis was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID) bioinformatics resources 48 and PANTHER 49 . For this purpose, all differentially expressed genes (corrected p-values < 0.05) between Glut1-tg and wild-type iT reg cell groups were split into two groups according to whether genes were downregulated or upregulated in the Glut1-tg experimental groups relative to the wild-type groups. PCR arrays. RNA was extracted as above and 1 µg total RNA was subjected to single-strand cDNA synthesis using the RT 2 first strand kit (Qiagen). The cDNA was used in the Glucose Metabolism and T cell Anergy and Immune Tolerance SuperArray RT 2 Profiler PCR arrays according to the manufacturer's instructions and assayed on a ViiA 7 (Applied Biosystems). Data were analyzed using the RT 2 Profiler program supplied by Qiagen and normalized to the geometric mean of the housekeeping genes beta-actin, beta-2 microglobulin, beta-glucuronidase and heat shock protein 90 kDa alpha.
Immunoblotting. Immunoblotting was performed as described previously 6 . Primary antibodies were followed by mouse-or rabbit-conjugated horseradish peroxidase (HRP). HRP-conjugated antibodies (anti-mouse or anti-rabbit IgG HRP conjugate, Promega) were detected by enhanced chemiluminescence detection (Thermofisher). This included the following antibodies: Akt (9272, Cell Signaling), Cpt1a (15184-1-AP, Proteintech group), Hif-1α (10006421, Cayman Chemical Company), phosphor-Akt (4060, Cell Signaling), PIK3cγ (ab140310, abcam), phosphor-mTOR (5536, Cell Signaling), PTEN (9552, Cell Signaling), phosphor-p70 S6K (9204, Cell Signaling). Alternatively, primary antibodies were followed by fluorescently labeled anti-mouse or rabbit antibodies (LiCor) and imaged using the Odyssey infrared imaging system (LiCor). This included the following antibodies: Glut1 (ab652, Abcam), hexokinase 2 (2867, Cell Signaling), hexokinase 1 (ab104835, Abcam), cytochrome C (556432, BD Biosciences), β-actin (A5441, Sigma) and phosphor-S6 (4858, Cell Signaling). All primary antibodies were used at a 1:1,000 dilution, with secondary HRP antibodies used at 1:8000. Secondary LiCor antibodies were used at 1:10000 (anti-mouse) or 1:8000 (anti-rabbit).
Metabolic assays. Glycolysis and glucose uptake assays using 3 H-glucose or 3 H-2-deoxyglucose have been described previously 6 . Glutamine oxidation, pentose phosphate pathway (PPP) flux and glucose oxidation were determined by the rate of 14 CO 2 release from U-14 C-glutamine, 1-14 C-glucose and 6-14 C-glucose as described 6 . All values were normalized to cell number. OCR and ECAR were measured with an XF24 extracellular flux analyzer (Seahorse Bioscience) as described 31 . Suspension cells were attached to culture plates using Cell-Tak (BD Bioscience). OCR and ECAR were measured in unbuffered DMEM (Sigma-Aldrich) supplemented with 10 mM D-glucose (SigmaAldrich) and 10 mM L-glutamine, as indicated. OCR and ECAR values were normalized to cell number. For certain experiments, ECAR was measured over time following injection of 10mM D-glucose, oligomycin and 2-deoxy glucose (2DG). Glycolytic capacity is defined as the difference between the ECAR following the injection of oligomycin and ECAR following glucose injection. Nontargeted metabolomic analyses were performed as described using LC Q Exactive Mass Spectrometer (LC-QE-MS) (Thermo Scientific) 6 .
T cell transfer model of colitis. Splenic CD4 T cells were isolated as described above, and naive effector (CD4 + CD25 − CD45RB hi ) T cells were sorted (FACSVantage; BD Bioscience). Naive effector T cells were injected intraperitoneally into 6-8-week-old C57BL/6 RAG1 −/− recipients (10 6 cells per mouse). Recipient animals were purchased from Jackson Labs and were assigned to groups randomly and co-housed in blinded fashion. Statistical analysis. Sample sizes were determined by prior experience and estimated power calculations. Statistical analyses were performed with Prism software (GraphPad). Data were analyzed using a two-tailed Student's t-test, and P < 0.05 was considered significant. Longitudinal data was analyzed by two-way ANOVA followed by Tukey's post hoc test.
